Your browser doesn't support javascript.
loading
Axonal damage in spinal cord is associated with gray matter atrophy in sensorimotor cortex in experimental autoimmune encephalomyelitis.
Meyer, Cassandra E; Gao, Josephine L; Cheng, James Ying-Jie; Oberoi, Mandavi R; Johnsonbaugh, Hadley; Lepore, Stefano; Kurth, Florian; Thurston, Mackenzie J; Itoh, Noriko; Patel, Kevin R; Voskuhl, Rhonda R; MacKenzie-Graham, Allan.
  • Meyer CE; Ahmanson-Lovelace Brain Mapping Center, Department of Neurology, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA/ UCLA Multiple Sclerosis Program, Department of Neurology, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA.
  • Gao JL; Ahmanson-Lovelace Brain Mapping Center, Department of Neurology, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA/ UCLA Multiple Sclerosis Program, Department of Neurology, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA.
  • Cheng JY; Ahmanson-Lovelace Brain Mapping Center, Department of Neurology, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA/ UCLA Multiple Sclerosis Program, Department of Neurology, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA.
  • Oberoi MR; Ahmanson-Lovelace Brain Mapping Center, Department of Neurology, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA/ UCLA Multiple Sclerosis Program, Department of Neurology, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA.
  • Johnsonbaugh H; Ahmanson-Lovelace Brain Mapping Center, Department of Neurology, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA/ UCLA Multiple Sclerosis Program, Department of Neurology, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA.
  • Lepore S; Ahmanson-Lovelace Brain Mapping Center, Department of Neurology, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA/ UCLA Multiple Sclerosis Program, Department of Neurology, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA.
  • Kurth F; Ahmanson-Lovelace Brain Mapping Center, Department of Neurology, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA/ UCLA Multiple Sclerosis Program, Department of Neurology, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA.
  • Thurston MJ; Ahmanson-Lovelace Brain Mapping Center, Department of Neurology, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA/ UCLA Multiple Sclerosis Program, Department of Neurology, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA.
  • Itoh N; UCLA Multiple Sclerosis Program, Department of Neurology, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA.
  • Patel KR; UCLA Multiple Sclerosis Program, Department of Neurology, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA.
  • Voskuhl RR; UCLA Multiple Sclerosis Program, Department of Neurology, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA.
  • MacKenzie-Graham A; Ahmanson-Lovelace Brain Mapping Center, Department of Neurology, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA/ UCLA Multiple Sclerosis Program, Department of Neurology, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA.
Mult Scler ; 26(3): 294-303, 2020 03.
Article en En | MEDLINE | ID: mdl-30843756
ABSTRACT

BACKGROUND:

Gray matter (GM) atrophy in brain is one of the best predictors of long-term disability in multiple sclerosis (MS), and recent findings have revealed that localized GM atrophy is associated with clinical disabilities. GM atrophy associated with each disability mapped to a distinct brain region, revealing a disability-specific atlas (DSA) of GM loss.

OBJECTIVE:

To uncover the mechanisms underlying the development of localized GM atrophy.

METHODS:

We used voxel-based morphometry (VBM) to evaluate localized GM atrophy and Clear Lipid-exchanged Acrylamide-hybridized Rigid Imaging-compatible Tissue-hYdrogel (CLARITY) to evaluate specific pathologies in mice with experimental autoimmune encephalomyelitis (EAE).

RESULTS:

We observed extensive GM atrophy throughout the cerebral cortex, with additional foci in the thalamus and caudoputamen, in mice with EAE compared to normal controls. Next, we generated pathology-specific atlases (PSAs), voxelwise mappings of the correlation between specific pathologies and localized GM atrophy. Interestingly, axonal damage (end-bulbs and ovoids) in the spinal cord strongly correlated with GM atrophy in the sensorimotor cortex of the brain.

CONCLUSION:

The combination of VBM with CLARITY in EAE can localize GM atrophy in brain that is associated with a specific pathology in spinal cord, revealing a PSA of GM loss.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Médula Espinal / Encefalomielitis Autoinmune Experimental / Sustancia Gris / Corteza Sensoriomotora / Esclerosis Múltiple Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Animals Idioma: En Año: 2020 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Médula Espinal / Encefalomielitis Autoinmune Experimental / Sustancia Gris / Corteza Sensoriomotora / Esclerosis Múltiple Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Animals Idioma: En Año: 2020 Tipo del documento: Article